A vaccine to combat C.Diff has shown promising results in initial trials and researchers hope to test the product in NHS hospitals later this year.
Vaccine hopes for C. Diff
The vaccine, being developed by Acambis, is claimed to combat the toxins produced by the infection. In a trial on 200 patients, the vaccine proved effective on one of the main toxins in 100% of cases and on a second main toxin in 75% of cases. It is hoped that a course of three injections may provide protection for over ten years.
